Sign in

CIK 0001699031 · Non-accelerated filer<br>Emerging growth company

GRAIL, Inc.

Sign in to watch
Ticker
GRAL
Exchange
Nasdaq
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863673636
Phone
(833) 694-2553
Business address
250 S. MATHILDA AVENUE, SUITE 100, SUNNYVALE, CA, 94086
Former names
GRAIL, LLC
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 144 Insider Sale of Securities
  4. 4 Open-market sale President sold 17,002 shares at an average $50.16 ($852,848)
  5. 4 Open-market sale Chief Financial Officer sold 9,573 shares at an average $50.17 ($480,244)
  6. 4 Open-market sale Chief Executive Officer sold 37,504 shares at an average $50.17 ($1,881,417)
  7. 144 Insider Sale of Securities
  8. 144 Insider Sale of Securities
  9. 144 Insider Sale of Securities
  10. 8-K Event Results of operations · Other events
  11. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  12. SCHEDULE 13G Stake Statement of Beneficial Ownership
  13. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 4 Grant or award Director acquired 213 shares (grant or award)
  16. 4 Grant or award Director acquired 329 shares (grant or award)
  17. 4 Grant or award Director acquired 206 shares (grant or award)
  18. 8-K Event Results of operations
  19. 4 Open-market sale President sold 13,000 shares at $100.00 ($1,300,000)
  20. 4 Open-market sale Chief Executive Officer sold 40,000 shares at an average $95.24 ($3,809,535)

Page 4 of 14 · 267 filings